TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Knowledge of students about the physiotherapist profession
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceptions of students about the physiotherapist profession
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Clinician Administered Post Traumatic Stress Disorder (PTSD) Scale (CAPS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mini International Neuropsychiatric Interview (MINI) Diagnosis of Psychiatric Disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PTSD Symptom Checklist (PCL-5) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dyspnea visual analogic scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery Self Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recovery-Promoting Relationships Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Neuropathic Pain Symptom Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measured Balance Value of the Medial Side of Knee during TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Measured Balance Value of the Lateral Side of Knee during TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Completion of Coaching Sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: AUC0-t of DWP16001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee injury consequences
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Participant reported function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Leg muscle atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Horizontal alveolar ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Endoscopic Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cough count per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Hand and Foot IGA 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland-Morris Disability Questionnaire Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intention to perform breast cancer early screening via mammogram
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nightingale Symptom Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACT-G Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AEs of special interest (immune-related AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: 9-hole pegboard test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription score
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fugl-Meyer scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fall incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Dizzy incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Voice-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants with Adverse Events after Intraperitoneal Chemotherapy Administration
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Surgical Complications after CRS, HIPEC and NIPEC-OXA
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative pain correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Hemoglobin value on haemorrhagic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hematocrit value on haemorrhagic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet count on haemorrhagic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Morphological changes of the palate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability as assessed by whether a participant would recommend the JovialityTM software
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Multipl sclerosis quality of life-54 (MSQOL-54)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in mean number of migraine days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from QuickDASH form results
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pelvic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Incidental thyroid cancer (ITC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum convex equivalent sphere values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fecal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in mental scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in gastrointestinal problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: peri-implant soft tissue health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Ratio of subjects with at least 50% improvement of their OAB/BD symptoms from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' Healthy Eating Index (HEI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mood and Anxiety Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breast engorgement assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: LATCH breastfeeding diagnostic scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: msitSBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Shock Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective perception during stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adenoma miss rate (AMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective radiographic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to treatment decision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: COVID-19 testing uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Flap complication
Endpoint domain: Adverse events/effects
Primary endpoint: Lung ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Marginal ulcer incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Variation of hepatic venous blood flow spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in plasma HbA1c concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endometrial Health Profile-30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual pattern Bleeding score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive Function (Cognitive Flexibility and Processing Speed)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brown Adipose Tissue Fat-signal Fraction Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Energy Expenditure Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Major Adverse Kidney Events within 30 days of randomization
Endpoint domain: Adverse events/effects
Primary endpoint: DNA methylation profile of sperm cells (first comparison; CHANGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA methylation profile of sperm cells (second comparison; CHANGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numerical Rating Scale (NRS) pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Risk: HIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PrEP Utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful Pain Reduction After 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Undetectable Measurable Residual Disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants That Reported Handwashing With Soap at Stool and Food Related Events
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Post Intervention Chlorine Concentration in Drinking Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of electrical signals around the Marshall vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: micro RNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Eligible Family Members Who Agree/Consent to Participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Enrolled Family Members Who Complete the Pilot Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Thrombus resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Feasibility of respiratory tele-physiotherapy program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lapses rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPA-axis response to stress exposure (cortisol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Immune system response to stress exposure (peripheral cytokines)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time from remission to relapse
Endpoint domain: Mortality/survival
Primary endpoint: Skin Capacitance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hopkins Symptom Checklist 25-item questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ankle pain (visual analogue score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MWT (Maintenance of Wakefulness Test) (minutes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ESS (Epworth Sleepiness Scale) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects experiencing treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects achieving sustained virologic response at 12 weeks post-treatment (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Near Transfer Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Transfer to Visual Search
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Transfer to Reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Transfer to Auditory Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with up-to-date vaccinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fluid status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar Stiffness Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in MSSBP after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Major Adverse Event Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Clinically Important Skin Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of ischemic cerebrovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Minutes of Gameplay Per Week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Persistent Vocalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MRI in diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of drainage fluid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of Inflammatory mediators in the drainage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Headache disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in myocardial micro-perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of major cardiovascular disease event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: poor cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of electric cardiometry in fluid management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical symptoms associated with breast disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Type of breast disease (benign or malignant)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Percent adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organoleptic properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of complications in the postoperative period
Endpoint domain: Adverse events/effects
Primary endpoint: Major procedure related complications - cardiac perforation
Endpoint domain: Adverse events/effects
Primary endpoint: Major procedure related complications - pericardial effusion with tamponade or requiring drainage
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from implantable cardioverter-defibrillator shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Variation of FSFI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neuromelanin Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in prescription of ICS+LABA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in prescription of ICS and SABA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in central aortic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of visits adherent to protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Computed cumulative fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder and non-responder patient identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional status identification (complete blood count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anthropometric measurements (weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reference Glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose concentration (various devices)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of EILO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Neural responses to cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on the attentional blink task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful use of HA380 column
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to recruit the sample size of eligible patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Histologic Classification (malignant vs. benign)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Charge from baseline adherence rates at 6 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of reported adherence barriers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Guideline concordant statin therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Guideline concordant inhaler therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intraocular dexamethasone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinetics of TG in VLDL1 and VLDL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of atrial fibrillation and sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: State and Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Obese-Specific Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Expression of the MGMT gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Methylation status of the MGMT promoter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Time to Stand (TTSTAND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Time to Run/Walk 10 meters (TTRW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Weekly Average Peak Pruritus Numeric Rating Scale (PP-NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Health Questionnaire-8 (PHQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anatomical characteristics on OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vascular characteristics on OCT-A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Myostatin (% increase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful recruitment time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful adherence to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Successful Retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall feasibility of this study will be assessed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timed 25-foot walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in postprandial glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in postprandial episodic memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Extremity Fugl-Meyer Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of near infrared spectroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal tolerance dose (MTD) of Oba01
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micronucleated cells in 2000 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes